Duvax
/ Nuravax
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 27, 2025
DU-PRISM: DUVAX Therapeutic Vaccine in Preclinical (Asymptomatic) Alzheimer's Disease: Phase 1: Safety, Tolerability, and Immunogenicity
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Nuravax, Inc.
New P1 trial • Alzheimer's Disease • CNS Disorders
1 to 1
Of
1
Go to page
1